Skip to main navigation Skip to search Skip to main content

Enhancing Renal Cell Carcinoma Response to IL-2 with the HDAC Inhibitor SNDX275

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/09 → 06/30/11

Funding

  • National Cancer Institute: $23,255.00